PROS1 and intrahepatic cholangiocarcinoma: The expression of protein corresponding to PROS1 mRNA was increased in the experimental group (peripheral plasma of ICC patients) compared to that in the control group (peripheral plasma of healthy subjects), however, the difference was not statistically significant (P=0.597799476).